Summary
The eosinophilia-myalgia syndrome associated with L-tryptophan-containing products is highlighted by eosinophilia, incapacitating myalgias, and diverse multisystemic manifestations. In addition to involvement of the skin, skeletal muscle, and peripheral nerves, visceral damage has been quite prominent, particularly affecting the lungs, the heart, and the liver. Hepatic involvement has been manifested by altered liver tests but is clinically silent. We report the unique case of a woman with this syndrome who developed abdominal pain, a clinical picture of hepatitis and chronically abnormal liver tests. Histologic examination of the liver disclosed eosinophilic hepatitis with piecemeal necrosis. The occurrence of clinically overt hepatic involvement has not been reported previously. Potential mechanisms of liver damage in eosinophilia-myalgia syndromes are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Herzman, P.A., Blevins, W.L., Mayer, J., Greenfield, B., Ting, M., Gleich, G.J. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990, 322, 869–873.
Sladek, G.D., Vasey, F.B., Sieger, B., Behnke, D.A., Germain, B.F., Espinoza, L.R. Relapsing eosinophilic myositis. J Rheumatol 1983, 10, 467–470.
Mayeno, A., Lin, F., Foote, C.S., Loegering, D.A., Ames, M.M., Hedberg, C.W., Gleich, G.J. Characterization of “peak E”, a novel amino acid associated with the eosinophilia-myalgia syndrome. Science 1990, 250, 1707–1708.
Martínez-Osuna, P., Wallach, P.M., Seleznick, M.J., Levin, R.W., Silveira, L.H., Jara, L.J., Espinoza, L.R. Treatment of the eosinophilia-myalgia syndrome. Semin Arthritis Rheum 1991, 20, 273–284.
Kaufman, Ld., Gruber, B.L., Gregersen, P.K. Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome. Lancet 1991, 1071–1074.
Philen, R.M., Eidson, M., Kilbourne, E.M., Sewell, C.M., Voorhees, R. Eosinophilia myalgia syndrome. A clinical case series of 21 patients, New Mexico eosinophilia-myalgia syndrome study group. Arch Intern Med 1991, 151, 533–537.
Martínez-Osuna, P., Espinoza, L.R. A limited form of the eosinophilia-myalgias syndrome (letter). Clin Exp Rheumatol 1991, 9, 307–308.
Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity: Consensus Development Conference Statement. Ann Intern Med 1991, 115, 956–961.
Lewis, J.H., Zimmerman, H.J. Drug-induced liver disease. Med Clin North Am 1989, 73, 775–792.
Varga, J., Uitto, J., Jiménez, S.A. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med 1991, 116, 437–442.
Loeliger, A.E., van den Brink, H.R., Derksen, R.H.W.M., Bijlsma, J.W.J. Eosinophilic fasciitis presenting with a reactive hepatitis. Clin Rheumatol 1991, 10, 440–444.
Foong, A., Scholes, J.V., Gleich, G.J., Kephart, G.M., Holt, P.R. Eosinophil-induced chronic active hepatitis in the idopathic hypereosinophilic syndrome. Hepatology 1991, 13, 1090–1094.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martinez-Osuna, P., Espinoza, C.G., Cuellar, M.L. et al. Eosinophilic hepatitis: A new feature of the clinical spectrum of the eosinophilia-myalgia syndrome. Clin Rheumatol 13, 528–532 (1994). https://doi.org/10.1007/BF02242958
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02242958